Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001140361-14-013049
Filing Date
2014-03-17
Accepted
2014-03-17 17:00:52
Documents
12
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 ASTERIAS BIOTHERAPEUTICS, INC 10-K 12-31-2013 form10k.htm 10-K 1534634
2 EXHIBIT 10.17 ex10_17.htm EX-10.17 662897
3 EXHIBIT 31 ex31.htm EX-31 14340
4 EXHIBIT 32 ex32.htm EX-32 5908
11 image00001.jpg GRAPHIC 45049
12 image00002.jpg GRAPHIC 4796
  Complete submission text file 0001140361-14-013049.txt   7176024

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ast-20131231.xml EX-101.INS 687511
6 XBRL TAXONOMY EXTENSION SCHEMA ast-20131231.xsd EX-101.SCH 45642
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ast-20131231_cal.xml EX-101.CAL 63789
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ast-20131231_def.xml EX-101.DEF 179690
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ast-20131231_lab.xml EX-101.LAB 631228
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ast-20131231_pre.xml EX-101.PRE 348692
Mailing Address 230 CONSTITUTION DRIVE MENLO PARK CA 94025
Business Address 230 CONSTITUTION DRIVE MENLO PARK CA 94025 510-521-3390
Asterias Biotherapeutics, Inc. (Filer) CIK: 0001572552 (see all company filings)

EIN.: 461047971 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-55046 | Film No.: 14698244
SIC: 2836 Biological Products, (No Diagnostic Substances)